Erratum for Winer et al., J Clin Oncol 27 (5) 812-826.

This Article Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Alert me to new issues of the journal Save to my personal folders Download to citation manager Rights & Permissions Social Bookmarking                            What's this?

ERRATUM

In the Breast Cancer section, under Major Advances, reference 3 should have been cited in the second to last sentence of the first paragraph instead of reference 1. In the last sentence of the paragraph, women older than 70 years should have been noted instead of women older than 70.2 years, and reference 4 should have been cited, as follows:

"A 2008 analysis of the same patient group found that the reduced risk of breast cancer recurrence persisted among all age groups, including women older than age 70 years.⁴"

In the last sentence of the second paragraph, references 5 and 6 should have been cited instead of references 3 and 4. In the last sentence of the fifth paragraph, reference 7 should have been cited instead of reference 5. In the last sentence of the sixth paragraph, reference 8 should have been cited instead of reference 6. In the first sentence of the last paragraph, reference 9 should have been cited instead of reference 7.

In the Breast Cancer section, under Notable Advances, reference 10a should have been cited in the last sentence of the third paragraph.

In the References section, the following references were inadvertently omitted:

8. Miller K, Wang M, Gralow J, et al: Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer. N Engl J Med 357:2666-2676, 2007.

9. Miles D, Chan A, Romieu G, et al: Randomized, double-blind, placebo-controlled, phase III study of bevacizumab with docetaxel or docetaxel with placebo as first-line therapy for patients with locally recurrent or metastatic breast cancer (mBC): AVADO. J Clin Oncol 26:43s, 2008 (suppl; abstr LBA1011)

10a. Goodwin PJ, Ennis M, Pritchard KI, et al: Vitamin D (Vit D) deficiency is common at breast cancer (BC) diagnosis and is associated with a significantly higher risk of distant recurrence and death in a prospective cohort study of T1-3, N0-1, M0 BC. J Clin Oncol 26:9s, 2008 (suppl; abstr 511)

The online version has been corrected in departure from the print.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?

This Article Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Alert me to new issues of the journal Save to my personal folders Download to citation manager Rights & Permissions Social Bookmarking                            What's this?